Article Versions Notes

Barbălată CI, Porfire AS, Sesarman A, Rauca V-F, Banciu M, Muntean D, Știufiuc R, Moldovan A, Moldovan C, Tomuță I. A Screening Study for the Development of Simvastatin-Doxorubicin Liposomes, a Co-Formulation with Future Perspectives in Colon Cancer Therapy. Pharmaceutics. 2021; 13(10):1526. https://doi.org/10.3390/pharmaceutics13101526

Barbălată, Cristina Ioana, Alina Silvia Porfire, Alina Sesarman, Valentin-Florian Rauca, Manuela Banciu, Dana Muntean, Rareș Știufiuc, Alin Moldovan, Cristian Moldovan, and Ioan Tomuță. 2021. "A Screening Study for the Development of Simvastatin-Doxorubicin Liposomes, a Co-Formulation with Future Perspectives in Colon Cancer Therapy" Pharmaceutics 13, no. 10: 1526. https://doi.org/10.3390/pharmaceutics13101526

Barbălată, C. I., Porfire, A. S., Sesarman, A., Rauca, V.-F., Banciu, M., Muntean, D., Știufiuc, R., Moldovan, A., Moldovan, C., & Tomuță, I. (2021). A Screening Study for the Development of Simvastatin-Doxorubicin Liposomes, a Co-Formulation with Future Perspectives in Colon Cancer Therapy. Pharmaceutics, 13(10), 1526. https://doi.org/10.3390/pharmaceutics13101526